AIKI Penny Stock Alert Update
PENNY STOCK ALERT UPDATE
AAIKI - AIkido Pharma Inc. - Common Stock Status Alert: Deficient
Initial Alert Price: $0.57
Price High: $2.14
% Gains/Losses: 275.44%
(+235% More Than Expected)
Potential Stop Loss: $2.033
AIKI hit $2.14 in yesterday's trading session providing a 275.44% Return on Investment from our initial trade alert on Nov. 30th. This was 2 days short of our typical 30 day swing trade timeframe. This was merely from momentum on the stock as the company has not released any news to justify the move otherwise. The stock has currently pull back and found support on the $1.41 Price Levels, so for now we will be closing this trade alert and looking for another potential re-entry if the stock does not hold these $1.41 Price Levels of Support #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
AAIKI - AIkido Pharma Inc. - Common Stock Status Alert: Deficient
Initial Alert Price: $0.57
Price High: $2.14
% Gains/Losses: 275.44%
(+235% More Than Expected)
Potential Stop Loss: $2.033
AIKI hit $2.14 in yesterday's trading session providing a 275.44% Return on Investment from our initial trade alert on Nov. 30th. This was 2 days short of our typical 30 day swing trade timeframe. This was merely from momentum on the stock as the company has not released any news to justify the move otherwise. The stock has currently pull back and found support on the $1.41 Price Levels, so for now we will be closing this trade alert and looking for another potential re-entry if the stock does not hold these $1.41 Price Levels of Support #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.